Mast cells and vascular diseases
Kennedy, Simon and Wu, Junxi and Wadsworth, Roger and Lawrence, Catherine and Maffia, Pasquale (2013) Mast cells and vascular diseases. Pharmacology and Therapeutics, 138 (1). pp. 53-65. ISSN 0163-7258 (https://doi.org/10.1016/j.pharmthera.2013.01.001)
Full text not available in this repository.Request a copyAbstract
Mast cells are increasingly being recognized as effector cells in many cardiovascular conditions. Many mast-cell-derived products such as tryptase and chymase can, through their enzymic action, have detrimental effects on blood vessel structure while mast cell-derived mediators such as cytokines and chemokines can perpetuate vascular inflammation. Mice lacking mast cells have been developed and these are providing an insight into how mast cells are involved in cardiovascular diseases and, as knowledge increase, mast cells may become a viable therapeutic target to slow progression of cardiovascular disease
ORCID iDs
Kennedy, Simon, Wu, Junxi ORCID: https://orcid.org/0000-0002-1334-887X, Wadsworth, Roger, Lawrence, Catherine ORCID: https://orcid.org/0000-0001-9928-8451 and Maffia, Pasquale;-
-
Item type: Article ID code: 43474 Dates: DateEventApril 2013Published16 January 2013Published OnlineSubjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 12 Apr 2013 08:52 Last modified: 11 Nov 2024 10:23 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/43474